FORT LAUDERDALE, Fla., Nov. 8, 2010 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company that markets both its RIO® Robotic Arm Interactive Orthopedic surgical platform and proprietary RESTORIS® implants for minimally invasive orthopedic procedures known as knee MAKOplasty®, today announced that it has closed the public offering of 6,325,000 shares of its common stock, which includes 825,000 shares issued and sold as a result of the underwriter’s exercise of its option to purchase additional shares to cover over-allotments. Piper Jaffray & Co. acted as the sole underwriter for the offering.
